A major pharma company turned to Escalent to ensure its early-stage product pipeline remains robust. Working directly with the Innovation Lead, who documents, vets, and owns status reports for innovation ideas from the worldwide employee base, we set out to define a more efficient process for:
Escalent conducted a three-phase approach using desk research, idea lifecycle management, and disease landscaping.
To validate and shortlist key innovative ideas, we conducted scientific literature research, researched clinical trial information and provided medical device landscaping.
Next, we improved process efficiency and reporting capabilities through enhanced report visualization. This enabled visibility into advancement of innovative ideas throughout the multi-stage vetting process.
Lastly, we assessed market conditions and obtained novel and current competitive treatment options within the therapeutic areas to vet ideas for potential commercialization.
As a result of Escalent’s partnership, our client is now set up with:
When you are in the business of saving millions of lives each year, it’s no surprise that healthcare entities leverage external consultative support to help make critical decisions. But how much return are pharma companies getting from their strategic consulting spend?
AI tools have already gotten a lot better from the first generation, but are they a viable substitute for the art and science of research and analytics? Not yet and maybe never. Escalent's Implementation Consultants can complete your complex tasks with speed.
See how businesses can leverage market research to navigate a choppy economy, avoid potential threats, and pursue new growth opportunities in 2023.
